Physicochemical Characterization and Phase I Study of CMAB008, an Infliximab Biosimilar Produced by a Different Expression System
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s170913
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2019
Authors
Publisher
Informa UK Limited